The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Cytokines in Inflammatory Bowel Disease
Abstract
Cytokines play a central role in the modulation of the intestinal immune system. They are produced by lymphocytes (especially T cells of the Th1 and Th2 phenotypes), monocytes, intestinal macrophages, granulocytes, epithelial cells, endothelial cells, and fibroblasts. They have proinflammatory functions [interleukin‐1 (IL‐1), tumor necrosis factor (TNF), IL‐6, IL‐8, IL‐12] or antiinflammatory functions [interleukin‐1 receptor antagonist (IL‐1ra), IL‐4, IL‐10, IL‐11, transforming growth factor β (TGFβ)]. Mucosal and systemic concentrations of many pro‐ and antiinflammatory cytokines are elevated in inflammatory bowel disease (IBD). An imbalance between proinflammatory and antiinflammatory cytokines was found for the IL‐1/IL‐1ra ratio in the inflamed mucosa of patients with Crohn's disease, ulcerative colitis, diverticulitis, and infectious colitis. Furthermore, the inhibition of proinflammatory cytokines and the supplementations with antiinflammatory cytokines reduced inflammation in animal models, such as the dextran sulfate colitis (DSS) model, the trinitrobenzene sulfonic acid (TNBS) model, or the genetically engineered model of IL‐10 knockout mice. Based on these findings a rationale for cytokine treatment was defined. The first clinical trials using neutralizing monoclonal antibodies against TNFα (cA2) or the antiinflammatory cytokine IL‐10 have shown promising results. However, many questions must be answered before cytokines can be considered standard therapy for IBD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IL-10 inhibits cytokine production by activated macrophages
Fiorentino, D. F., Zlotnik, A., Mosmann, T. R., Howard, M., & O’Garra, A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.11.3815 · Cited by 2,888
Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils.
Baggiolini, M., Walz, A., & Kunkel, S. L. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114265 · Cited by 1,975
Kulkarni, A. B., Huh, C. G., Becker, D., Geiser, A., Lyght, M., Flanders, K. C., Roberts, A. B., Sporn, M. B., Ward, J. M., & Karlsson, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.770 · Cited by 1,967
de Waal Malefyt, R., Haanen, J., Spits, H., Roncarolo, M. G., te Velde, A., Figdor, C., Johnson, K., Kastelein, R., Yssel, H., & de Vries, J. E. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.4.915 · Cited by 1,930
Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene
Sadlack, B., Merz, H., Schorle, H., Schimpl, A., Feller, A. C., & Horak, I. (1993) · Cell · doi:10.1016/0092-8674(93)80067-o · Cited by 1,744
Transforming growth factor type beta induces monocyte chemotaxis and growth factor production.
Wahl, S. M., Hunt, D. A., Wakefield, L. M., McCartney-Francis, N., Wahl, L. M., Roberts, A. B., & Sporn, M. B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.16.5788 · Cited by 1,272
Fuss, I. J., Neurath, M., Boirivant, M., Klein, J. S., de la Motte, C., Strong, S. A., Fiocchi, C., & Strober, W. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.3.1261 · Cited by 1,227
Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)
van Dullemen, H. M., van Deventer, S. J. H., Hommes, D. W., Bijl, H. A., Jansen, J., Tytgat, G. N. J., & Woody, J. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90277-5 · Cited by 1,084
REINECKER, H.-C., STEFFEN, M., WITTHOEFT, T., PFLUEGER, I., SCHREIBER, S., MacDERMOTT, R. P., & RAEDLER, A. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1993.tb05997.x · Cited by 856
The interleukin‐1 family: 10 years of discovery 1
Dinarello, C. A. (1994) · The FASEB Journal · doi:10.1096/fasebj.8.15.8001745 · Cited by 783
Cited by
Terzić, J., Grivennikov, S., Karin, E., & Karin, M. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.058 · Cited by 1,974
Cytokines and major depression
Schiepers, O. J. G., Wichers, M. C., & Maes, M. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.11.003 · Cited by 1,235
Molecular Mechanisms RegulatinG Th1 Immune Responses
Szabo, S. J., Sullivan, B. M., Peng, S. L., & Glimcher, L. H. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.140942 · Cited by 1,019
The Contribution of Interleukin‐1 and Tumor Necrosis Factor to Periodontal Tissue Destruction
Graves, D. T., & Cochran, D. (2003) · Journal of Periodontology · doi:10.1902/jop.2003.74.3.391 · Cited by 1,003
Kim, H. J., Li, H., Collins, J. J., & Ingber, D. E. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522193112 · Cited by 922
Cytokines and the Brain: Implications for Clinical Psychiatry
Kronfol, Z., & Remick, D. G. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.683 · Cited by 784
Role of cytokines in inflammatory bowel disease
Sanchez-Muñoz, F., Dominguez-Lopez, A., & Yamamoto-Furusho, J. K. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.4280 · Cited by 699
Nagoor Meeran, M. F., Javed, H., Al Taee, H., Azimullah, S., & Ojha, S. K. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00380 · Cited by 602
Inflammation and colorectal cancer: colitis-associated neoplasia
Grivennikov, S. I. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-012-0352-6 · Cited by 551
Cis3/Socs3/Ssi3 Plays a Negative Regulatory Role in Stat3 Activation and Intestinal Inflammation
Suzuki, A., Hanada, T., Mitsuyama, K., Yoshida, T., Kamizono, S., Hoshino, T., Kubo, M., Yamashita, A., Okabe, M., Takeda, K., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.4.471 · Cited by 471
Anti-inflammatory mechanisms of bioactive milk proteins in the intestine of newborns
Chatterton, D. E. W., Nguyen, D. N., Bering, S. B., & Sangild, P. T. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.04.028 · Cited by 402
Egger, B., Bajaj-Elliott, M., MacDonald, T. T., Inglin, R., Eysselein, V. E., & Büchler, M. W. (2000) · Digestion · doi:10.1159/000007822 · Cited by 384
Hampe, J., Schreiber, S., Shaw, S. H., Lau, K. F., Bridger, S., Macpherson, A. J. S., Cardon, L. R., Sakul, H., Harris, T. J. R., Buckler, A., et al. (1999) · The American Journal of Human Genetics · doi:10.1086/302294 · Cited by 375
Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice
Ito, R., Shin-Ya, M., Kishida, T., Urano, A., Takada, R., Sakagami, J., Imanishi, J., Kita, M., Ueda, Y., Iwakura, Y., et al. (2006) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2006.03214.x · Cited by 364
Laroui, H., Ingersoll, S. A., Liu, H. C., Baker, M. T., Ayyadurai, S., Charania, M. A., Laroui, F., Yan, Y., Sitaraman, S. V., & Merlin, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032084 · Cited by 346
Jang, Y. J., Kim, W.-K., Han, D. H., Lee, K., & Ko, G. (2019) · Gut Microbes · doi:10.1080/19490976.2019.1589281 · Cited by 296
The Inhibitory Effects of Transforming Growth Factor-Beta-1 (TGF-β1) in Autoimmune Diseases
Prud'homme, G. J., & Piccirillo, C. A. (2000) · Journal of Autoimmunity · doi:10.1006/jaut.1999.0339 · Cited by 276
Scorpion Venom and the Inflammatory Response
Petricevich, V. L. (2010) · Mediators of Inflammation · doi:10.1155/2010/903295 · Cited by 273
Nutritional deficiencies in patients with Crohnʼs disease in remission
Filippi, J., Al-Jaouni, R., Wiroth, J.-B., Hébuterne, X., & Schneider, S. M. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000206541.15963.c3 · Cited by 263
Curcumin prevents and ameliorates trinitrobenzene sulfonic acid–induced colitis in mice
Sugimoto, K., Hanai, H., Tozawa, K., Aoshi, T., Uchijima, M., Nagata, T., & Koide, Y. (2002) · Gastroenterology · doi:10.1053/gast.2002.37050 · Cited by 262
Martı&#x;n, A. R., Villegas, I., La Casa, C., & de la Lastra, C. A. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2003.12.024 · Cited by 258
Immune dysfunction in inflammatory bowel disease
Neuman, M. G. (2007) · Translational Research · doi:10.1016/j.trsl.2006.11.009 · Cited by 255
Pellissier, S., Dantzer, C., Mondillon, L., Trocme, C., Gauchez, A.-S., Ducros, V., Mathieu, N., Toussaint, B., Fournier, A., Canini, F., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105328 · Cited by 212
Mangiferin: A xanthonoid with multipotent anti‐inflammatory potential
Saha, S., Sadhukhan, P., & Sil, P. C. (2016) · BioFactors · doi:10.1002/biof.1292 · Cited by 166
van Hemert, S., Breedveld, A. C., Rovers, J. M. P., Vermeiden, J. P. W., Witteman, B. J. M., Smits, M. G., & de Roos, N. M. (2014) · Frontiers in Neurology · doi:10.3389/fneur.2014.00241 · Cited by 150
IL1β‐ and LPS‐induced serotonin secretion is increased in EC cells derived from Crohn’s disease
Kidd, M., Gustafsson, B. I., Drozdov, I., & Modlin, I. M. (2009) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2008.01210.x · Cited by 130
The Gut-Brain Axis in Inflammatory Bowel Disease—Current and Future Perspectives
Günther, C., Rothhammer, V., Karow, M., Neurath, M., & Winner, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168870 · Cited by 123
Effects of a Combination of Thyme and Oregano Essential Oils on TNBS-Induced Colitis in Mice
Bukovská, A., Cikoš, Š., Juhás, Š., Il’ková, G., Rehák, P., & Koppel, J. (2007) · Mediators of Inflammation · doi:10.1155/2007/23296 · Cited by 125
The role of neuroinflammation on pathogenesis of affective disorders
Rhie, S. J., Jung, E.-Y., & Shim, I. (2020) · Journal of Exercise Rehabilitation · doi:10.12965/jer.2040016.008 · Cited by 126
MATSUMOTO, S., NAGAOKA, M., HARA, T., KIMURA-TAKAGI, I., MISTUYAMA, K., & UEYAMA, S. (2004) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2004.02462.x · Cited by 113
Benson, S., Kattoor, J., Wegner, A., Hammes, F., Reidick, D., Grigoleit, J.-S., Engler, H., Oberbeck, R., Schedlowski, M., & Elsenbruch, S. (2012) · Pain · doi:10.1016/j.pain.2011.12.001 · Cited by 89
Aktunc, E., Kayhan, B., Arasli, M., Gun, B. D., & Barut, F. (2011) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2011.559475 · Cited by 44
Stress-related peripheral neuroendocrine–immune interactions in women with ulcerative colitis
Langhorst, J., Cobelens, P. M., Kavelaars, A., Heijnen, C. J., Benson, S., Rifaie, N., Dobos, G. J., Schedlowski, M., & Elsenbruch, S. (2007) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.09.003 · Cited by 35
Metadata
- Authors
- Rogler, G., & Andus, T.
- Venue
- World Journal of Surgery
- Publisher
- Wiley
- Published
- 1998-04
- Volume
- 22
- Issue
- 4
- Pages
- 382-389
- ISSN
- 0364-2313 (ISSN-L)
- 1432-2323
- OpenAlex
- W1966961395
- Cited by
- 484
- References
- 66
- FWCI
- 7.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.